June 06, 2014
A roundup of news on drug resistance and other topics in global health.
The documentary Resistance will be screening at the E Street Cinema in Washington, DC, on Wednesday, June 11. CDDEP Director Ramanan Laxminarayan was interviewed for the film and he, along with other experts in the field, will take part in a discussion on antibiotic resistance following the screening. Space is limited and RSVPs are required for this free event! Click here for more information and be sure to send your RSVP to [email protected].
In December the Lancet Commission on Investing in Health released its report “Global Health 2035: A world converging within a generation”. CDDEP interviewed Commissioner Gavin Yamey on global reactions to the report’s recommendations in the six months since its release. [CDDEP]
A single-dose antibiotic that can clear MRSA may be approved by the FDA as early as August through a special fast-track process. [New York Times]
A plan to limit the size of containers for sugary drinks sold in New York City restaurants to 16 ounces was revived in the New York State Court of Appeals on Wednesday. If passed, the law could set a new precedent for how far local governments can go to protect the health of their citizens. [The Atlantic, The New York Times]
Advertising for electronic cigarettes has skyrocketed in the US over the past several years and seems to be targeted at adolescents and young adults. [American Academy of Pediatrics]
Mobile technology is playing an increasingly important role in life-saving global health initiatives. [The Guardian]
With the threat of antibiotic-resistant pathogens becoming ever more prevalent, researchers are looking more closely at phage therapy to treat bacterial infections. [The Scientific American]
Adopting a series of measures to enhance program management could be key in fighting malaria in developing countries, according to a new paper funded by the Bill & Melinda Gates Foundation and led by University of Exeter Professor Jonathan Gosling. [MedicalXpress]
The FDA this week approved a new drug, Dalvance, for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). [CNN]
Researchers on the Thai-Burma border say that a new drug-resistant strain of malaria could pose a danger to communities in India and Africa if it is not controlled. [The Guardian]
Want to share interesting news via the Digest? Please send an email to [email protected].
To receive the Weekly Digest in your inbox, please enter your e-mail address in the “Receive Updates” box.
Image via Wellcome Images/Flickr.
